280E and licensing structures for brand companies
A cannabis brand company that licenses trademarks, formulations and packaging design to a licensed New Jersey manufacturer or dispensary, rather than holding a license itself, generally earns royalty income that is not directly subject to 280E's trafficking limitation, since the licensor is not itself selling cannabis. That said, the royalty agreement and its pricing must reflect arm's-length terms, or the IRS may attempt to collapse the structure and apply 280E to the combined enterprise.
This distinction traces directly to the trade-or-business analysis in CHAMP and the capitalization framework in Olive: separating the intangible-asset business from the plant-touching business only holds up when the two are operated, invoiced and priced as genuinely separate enterprises.
Multi-entity structuring and royalty revenue mechanics
Structuring the IP-holding entity separately from the licensed New Jersey operator requires formal intercompany agreements, consistent transfer pricing and clean books at both entities, not merely a licensing agreement filed away and forgotten. Marketing, packaging design and brand-development spend, generally fully deductible at the brand entity, must be clearly segregated from any costs the affiliated licensed operator incurs.
Royalty income is typically calculated as a percentage of the licensed partner's wholesale or retail sales volume, which in New Jersey is generally sourced from Metrc-based sales reporting; revenue recognition systems need to reconcile that licensee sales data to royalty invoicing promptly to avoid lagging or disputed royalty statements.
- Arm's-length royalty agreements with documented transfer pricing
- Full deductibility of marketing and brand-development spend at the licensor entity
- Royalty revenue tied to licensee's Metrc-sourced sales volume
New Jersey tax planning for licensing entities
The non-plant-touching brand entity generally files New Jersey returns without 280E limitation regardless of the state's decoupling rules, since 280E would not have applied to it federally in the first place, but coordination between the brand entity and the licensed operating entity's own New Jersey filings, which do benefit from the P.L. 2023, c.50 decoupling, is essential to avoid inconsistent reporting across the affiliated group.
We build the accounting system first and let the tax return follow it. If you operate a licensed New Jersey cannabis brand, a diagnostic review will quantify what your current treatment is costing you before any engagement begins.
